TG Therapeutics, Inc. (TGTX)
34.02
-1.36
(-3.84%)
USD |
NASDAQ |
Apr 28, 16:00
34.02
0.00 (0.00%)
After-Hours: 20:00
TG Therapeutics Research and Development Expense (TTM) : 160.22M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Precision BioSciences, Inc. | 52.87M |
| Krystal Biotech, Inc. | 55.08M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Geron Corp. | 73.72M |
| Viking Therapeutics, Inc. | 344.96M |